NPCE
NASDAQ HealthcareNeuropace, Inc. - Common Stock
Medical Devices
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
�� 市场数据
| 价格 | $17.07 |
|---|---|
| 成交量 | 152,490 |
| 市值 | 579.53M |
| 贝塔系数 | 1.880 |
| RSI（14日） | 74.1 超买 |
| 200日均线 | $13.06 |
| 50日均线 | $14.73 |
| 52周最高 | $18.98 |
| 52周最低 | $7.56 |
| Forward P/E | -49.06 |
| Price / Book | 30.11 |
🎯 投资策略评分
NPCE 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (89/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 💰 Dividend Daddy (7/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 NPCE in your text
粘贴任何文章、记录或帖子 — 工具将提取 NPCE 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-05-01.